Why Twist Bioscience's Shares Rose 25.1% in July

Shares of Twist Bioscience (NASDAQ: TWST), a biotech company that makes synthetic DNA-based products, including synthetic genes, antibody libraries for drug development and tools for next-generation sample preparation, jumped 25.1% in July, according to according to data from S&P Global Intelligence. On July 14, the company announced that it was launching two monkeypox virus synthetic DNA controls, including the Congo Basin clade (genetic branch) from Central Africa and the West African clade. The second bit of news that helped drive up Twist's shares was that Cathie Wood's ARK Innovation ETF bought an additional 156,417 shares of Twist in July, raising the ETF's number of Twist shares to 6.27 million, making it the second-largest holder of Twist shares.